Target intelligence / Profile preview

SEZ6L antisense RNA 1 (SEZ6L-AS1)

Target: SEZ6L-AS1
Molecular classification: Other, Long non-coding RNA

Overview

SEZ6L antisense RNA 1 (SEZ6L-AS1) is a non-coding RNA transcribed from the antisense strand of the SEZ6L gene locus. Unlike SEZ6L or SEZ6L2, which encode transmembrane proteins with roles in neuronal biology and cancer, SEZ6L-AS1's molecular and clinical relevance as a drug target has not been described. It belongs to a class of long non-coding RNAs often involved in the regulation of gene expression via epigenetic, transcriptional, or post-transcriptional mechanisms, but further details are lacking in current datasets. SEZ6L-AS1 is not generally described or recognized as a therapeutic target in the conventional sense. Existing studies and resources focus on the protein-coding gene SEZ6L, not its antisense non-coding RNA. If you are seeking information about a classic receptor, transporter, or enzyme, SEZ6L-AS1 is not the correct target; consider SEZ6L (Seizure related 6-like protein) or SEZ6L2 (Seizure related 6-like 2 protein) instead.

Other names: SEZ6L-AS1Seizure related 6-like antisense RNA 1

Biological functions

Potential regulation of gene expression by antisense interaction (general non-coding RNA function)No confirmed role as receptor, transporter, or enzyme

Disease associations

Other (No specific disease association established for SEZ6L-AS1; literature on SEZ6L and SEZ6L2 suggests roles in neuropsychiatric diseases and cancer, but not for SEZ6L-AS1 specifically)

Beyond the preview

Go deeper on SEZ6L antisense RNA 1 (SEZ6L-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SEZ6L antisense RNA 1 (SEZ6L-AS1).

Explore the full profile